Tech Company Financing Transactions

Clarus Therapeutics Funding Round

Clarus Therapeutics closed a $4 million financing round on 3/31/2013. Backers included ProQuest Investments, Thomas, McNerny & Partners and private investors.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

555 Skokie Blvd. 340
Northbrook, IL 60062
USA

Phone

(847) 562-4300

Website

www.clarustherapeutics.com

Email Address

[email protected]

Overview

Clarus Therapeutics is an emerging men s health specialty pharmaceutical company preparing for the commercial launch of REXTORO, our oral testosterone (T) replacement therapy.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Robert Dudley

        

Chief Financial Officer

Steven Bourne

        

Chief Medical Officer

Theodore Danoff

        

Browse more venture capital transactions:

Prev: 3/31/2013: FutureDerm venture capital transaction
Next: 3/31/2013: Intralign Health venture capital transaction

Share this article

News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary